There is no translation available.
Do you own ACTELION ?
I remember the stock was traded at CHF 30 in the late-nineties, before split ! It was at that time I began to follow the company.
After twenty years, the company has decided today to accept the takeover price per share of CHF 280, from Johnson & Johnson equivalent to a $ 30 billion transaction value.
Built on one drug sales (Pulmonary Arterial Hypertension), the company expanded its turnover through the search and development of innovative drugs for diseases with significant unmet medical needs.
This is a great story thanks to Mrs and Mr Clozel with a happy end for shareholders.
Now, what can we do with cash ?
Please meet one of our Partners to be informed of the latest investment opportunities.
Click on iThis email address is being protected from spambots. You need JavaScript enabled to view it.
